Introduction
The medical management and prevention of many conditions rely on the prescribing and use of medicines. Yet, for a variety of reasons, patients commonly fail to adhere to medication instructions. 1, 2 The issue of medication nonadherence is particularly 
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hindi et al problematic with chronic conditions where adherence is estimated to be around 50%. 3 Medication nonadherence potentially reduces clinical benefit and quality of life in patients, in turn increasing the burden of ill health, medicines waste, hospitalization, emergency admissions, and death. 4 As a potential solution, medication adherence reviews are offered as a pharmacy service across a number of European countries, including the United Kingdom. 5 In the UK, the Medicines Use Review (MUR) service consists of a yearly one-to-one patient-pharmacist consultation; introduced in 2005, the aim of the service is to address concerns and questions about all of a patient's medication to improve their adherence. 6 Yet, patients' satisfaction with the service has not been formally measured. Internationally, the World Health Organization has emphasized the importance of the patient's perspective in the evaluation of health services. 7 Patient satisfaction is broadly conceptualized as the extent to which a patient is content with a health service encounter. As well as being a significant indicator of the perceived quality of care and success of health care services in general, 8, 9 past research has demonstrated patient satisfaction to be a key determinant of adherence to medical advice. 10 Logically, if patients are satisfied with a service such as the MUR, this has the potential to improve their adherence, and measuring patient satisfaction, for example using a questionnaire, could then become a valid mechanism for auditing service quality. 7, 11 But existing pharmacy patient satisfaction questionnaires offer limited scope as detailed in the following paragraphs.
The hallmark of a good questionnaire is one that fully captures all of the constructs relating to the concept it is measuring. 12 An in-depth review conducted by Panvelkar et al 13 evaluated five instruments for measuring patient satisfaction with community pharmacy services per se, none of which was developed by collaborating with patients to obtain their perspectives on the topic. Moreover, only two of the instruments 14, 15 focused on patient satisfaction with services that might resemble the MUR, and while one requires further testing 14 the other was developed in the Spanish language. 15 A different, more recently published study can also be criticized for not being based on patients' own perspectives of the pharmacy service in question. 16 Examining the broader concept of pharmaceutical care services provided for outpatients, a more recent review of patient satisfaction questionnaires unearthed 12 studies, but highlighted that only one study had developed an instrument to be directly applied in the evaluation of community pharmacy services. 17 The authors recommended that consistent with Donabedian's framework, 18 future research should be directed toward the development and validation of structure, process, and outcome indicators for evaluating the quality of pharmaceutical care services. The constructs identified by patients as being important to their experience and satisfaction with the MUR have in fact been previously mapped against Donabedian's structure-process-outcome framework. 19 Based on the MUR patient satisfaction framework, 19 the current paper aimed to assess patient satisfaction with the MUR service by developing, piloting, and utilizing a new MUR patient satisfaction questionnaire (MUR-PSQ), which was completed and is described here. 
Materials and methods compliance with ethical standards

instrument development and content validation
The MUR-PSQ version 1 (v1) was designed to have items that were relevant to patient satisfaction with the MUR service 19 and be simple and easy to understand, with clear instructions, and a reasonable completion time (,10 minutes). Therefore there were no negatively worded items or reverse scoring of any item. The MUR-PSQ-v1 included 12 positively worded questions (items) each with a 5-point Likert response scale (1= strongly disagree to 5= strongly agree). A comments box was also added to check that the questionnaire captured all of the relevant concepts being expressed by people experiencing the service.
Ascertaining the content validity index (CVI) was deemed appropriate for establishing the content validity (CV) of the questionnaire. This is because CVI measures the extent of agreement between experts about each questionnaire item (hereon referred to as the item CVI; I-CVI), and this helps improve each question where needed. 20 A panel of 12 pharmacists involved in patient care (eg, community or hospital pharmacy posts) was recruited for the CV exercise. Specifically, a set of three questions for validating each item of the MUR-PSQ-v1 (Table 1) was devised by adapting an established cognitive theory model for determining CV. 21 Each pharmacist panel member was asked to read each of the items on the MUR-PSQ-v1 in turn and answer three distinct CV questions on a 4-point Likert response scale from (1= strongly disagree to 4= strongly agree). The three distinct CV questions were "Q1. This question is easy to understand," "Q2.
The responses available are appropriate for the question asked" and "Q3. This question is relevant to measuring patient satisfaction with an MUR service."
The I-CVI was determined by calculating the proportion of panel members who gave a rating of 3 or 4 (agree or strongly agree) to each of three CV questions relating to each questionnaire item. An I-CVI of $0.83 (10 ratings of 3 or 4 from 12 ratings) was judged as the minimum acceptable value for the combined rating for responses to each CV question. This minimum acceptable value was based on Lynn's criteria, 22 and any item not receiving the minimum acceptable value for any of the three CV questions was subjected to revision and re-evaluation.
The response options were judged to be appropriate for all 12 items of the questionnaire (CV Q2 I-CVI $0.83), and all 12 items were judged to be relevant (CV Q3 I-CVI $0.83) for measuring patient satisfaction with MURs ( Table 1) . The panel recommended rephrasing three items (items 4, 5, and 12) for greater clarity (CV Q1). The wording of these was amended to produce a second version of the MUR-PSQ version 2. A further review by the panel deemed all three revised items to be acceptable (I-CVI $0.83).
In addition to the this, the appropriateness and understandability of the MUR-PSQ-v1 in the target population was examined with the help of three community pharmacists in the East of England, who handed out the MUR-PSQ-v1 (and accompanying information letters and return envelopes) to 60 patients following an MUR consultation during February-April 2016. Patients in turn posted their selfcompleted questionnaire to the University for the authors' attention. The returned questionnaires (n=30) were completed in full, and no comments regarding the questionnaire layout or wording were reported.
instrument testing
The revised questionnaire (MUR-PSQ-v2) was distributed to 250 community pharmacies belonging to one pharmacy chain in England (covering the South East, Central, and West of England, but with branches also in the North of England) between June and October 2016. Each pharmacy involved in the study received 20 patient questionnaire packs for distribution. The questionnaire packs contained the MUR-PSQ-v2, an accompanying information letter, two copies of a written informed consent form, and a return envelope (addressed to the University for the authors' attention). Each pharmacy also received a letter inviting the pharmacist to take part by handing out one questionnaire pack to each patient following an MUR consultation. It was not possible to accurately determine the number of patient packs handed out, but an attempt was made to estimate this through a retrospective telephone survey completed with the 250 pharmacies. This involved one of the coauthors (CP) telephoning each pharmacy branch to ask about the number of questionnaire packs given out/remaining from the batch of 20 packs sent to them. Patients in turn posted their self-completed questionnaire and one copy of the signed written informed consent form to the authors, thus allowing an estimation of the response rate to be made by dividing the number of responses returned to the researchers by the total number of patient packs which pharmacists declared to have handed out.
On receipt, the questionnaire responses were analyzed using the Statistical Software for Social Sciences version 21 (IBM Corp., Armonk, NY, USA). Exploratory factor analysis was carried out to identify, understand, and interpret the relationships between the items on the MUR-PSQ-v2, explicitly in order to determine independent latent constructs known as "factors." As part of the analysis, the correlation between the variables was examined by creating a correlation matrix.
The Kaiser-Meyer-Olkin (KMO) value was used to evaluate sample adequacy for factor analysis, where a KMO of 0.5 is considered to be minimum, 0.5-0.7 mediocre, 0.7-0.8 good, 0.8-0.9 great, and .0.9 superb. 23 Bartlett's test of sphericity was also completed to ensure that the study assumptions were satisfied for factor analysis by looking for a statistically significant value of less than 0.05. A number of procedures exist to determine the optimal number of factors to retain in exploratory factor analysis. In this study, based on Kaiser's criteria, 23 factors with eigenvalues greater than 1 were selected. Also, the scree plot method, 23 a subjective test requiring researchers' judgment, was used to confirm factor findings. Construct validity was confirmed if the factors accounted for a minimum of 50% of the variance. 24 Items on the questionnaire were grouped into factors based on the factor loadings, and an item was considered significant if its loading was $0.40. 25 To retain an item, the factor loading of the item was higher than 0.30. Cronbach's α was used to measure the instrument's internal reliability by evaluating the consistency of responses between the items contained within any identified factors on the MUR-PSQ-v2. 26 The MUR-PSQ-v2 survey responses were also examined for patient-reported satisfaction with MURs. In addition, the handwritten comments received were analyzed by theoretical thematic analysis, 27 meaning data were examined, coded, and themed for ideas that related to the research question, ie, patients' satisfaction with MURs. The themes generated were juxtaposed against items on the MUR-PSQ-V2 to check if the questionnaire captured all of these concepts.
Results
All 250 branches of a community pharmacy chain (covering mainly the South East, Central, and West of England, but with branches also in the North of England) were invited to take part by handing out one questionnaire pack to each patient following an MUR consultation. A telephone survey completed between November and December 2016 estimated that 2,151 questionnaires had been given out to patients. A total of 505 questionnaires were returned by patients to the authors, resulting in an estimated response rate of 24%.
exploratory factor analysis & reliability testing
The intercorrelation between all the items was 0.2-0.825, which provided an indication that all the individual items were interrelated yet not redundant or highly correlated (Table S1) . 23 A high KMO value of 0.94 confirmed that the sample was acceptable for factor analysis. 23 Additionally, Bartlett's test of sphericity (4,229.155, df=66, p=0.000) confirmed that the assumptions for factor analysis were satisfied in this study. Based on the Kaisers criteria, in which factors with eigenvalue .1 are retained (Table S2) , factor analysis presented two factors, with a cumulative variance of 68.8%. The presence of two factors was also confirmed with the scree plot.
None of the items loaded significantly onto both factors, thereby indicating the uniqueness of each individual item and its specificity to a certain factor ( Table 2 ). The first factor had 7 items and was labeled as "experiencing the service", while the other 5 items loaded onto factor 2 which was labeled as "judging the service." Furthermore, reliability analysis using Cronbach's α revealed that all items on factor 1 (α=0.90) and factor 2 (α=0.89) had excellent internal consistency.
Patient satisfaction with the MUr
A total of 489 people (97%) agreed or strongly agreed that they were satisfied with the MUR service they had received (Table S3 , specifically responses to item 12). Agreement was highest in relation to satisfaction with the time spent by the pharmacist listening (98%) and the pharmacist's personal approach toward the patient (98%). There was also high satisfaction with explanations of the aims of the service (96%), 
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MUr patient satisfaction questionnaire the comfort and privacy of the consultation room (96%), the opportunity to raise questions or concerns (97%) and have these answered (95%), and generally the pharmacists' advice and recommendations (96%). Eight out of ten patients agreed they felt more confident about their condition following the MUR. Interestingly, only 328 people (65%) had wanted to have an MUR at the outset. Despite this, nine out of ten people would use the service again, and the same number would recommend it to others. The handwritten comments on the returned questionnaires were grouped into four main themes, which are shown below with illustrative quotes. The themes identified could all be mapped against the items on the MUR-PSQ-v2 (Table 3) . 
Discussion
A new questionnaire was devised, piloted, and tested for the purpose of measuring patient satisfaction with the MUR service in the UK. The CVI and piloting established the clarity, relevance, and appropriateness of all 12 items on the MUR-PSQ-v2. Exploratory factor analysis extracted two unique factors labeled as "experiencing the service" and "judging the service" without dual loadings. Moreover, Cronbach's α revealed high internal consistency between the items grouped under each of the two factors. The results of the survey infer a high degree of patient satisfaction with experiencing the MUR service as well as with judging its impact although this result is not conclusive considering the low response rate, which was estimated to be 24%. The two factors identified through factor analysis, "experiencing the service" and "judging the service", concurred with the layout of the MUR-PSQ-v2, in which the first half focuses on the patient experience with the consultation while the second half focuses on the outcomes and evaluations of the MUR service itself. These two factors bear some important similarities and differences with factors identified in previous patient satisfaction questionnaires. Previous questionnaires examining patient satisfaction with pharmacy services have generated multiple factors that are arguably irrelevant to the MUR adherence-focused service, including factors such as "financial aspects," "product availability", and "technical quality." 15, 28, 29 While the updated MacKeigan and Larson tool 14 produced two dimensions that share some commonality with the "experiencing the service" factor, the MUR-PSQ-v2 factor "judging the service" is new, perhaps because the current questionnaire is rooted in patients' perspectives, which is detailed elsewhere. 19 In comparison to previous instruments, [14] [15] [16] [28] [29] [30] limiting the questionnaire to 12 specific items also avoided drawbacks commonly identified in previous surveys such as lengthy completion time and multiple dual loadings.
When analyzing people's responses on the MUR-PSQ-v2, a high degree of satisfaction with the MUR service was found, which as stated earlier, needs to be treated with caution in light of the low response rate. This is in line with two previous formal studies that have shown high patient satisfaction with community pharmacy services 16, 30 and with one study that more informally examined patient satisfaction with the MUR service. 31 Of particular interest was item 7, "I wanted to have an MUR consultation', which produced a considerably lower score than all the other items -ie, 33% of the respondents did not agree/strongly agree with this statement. Despite this response, patients who received the MUR service and returned the questionnaire were very satisfied with it. Similarly, previous qualitative studies showed that patients who take part in MURs did not necessarily want the service at first or think they will benefit from it. 19, 32 This is in line with a general reluctance to use community pharmacy services, as reported elsewhere. [33] [34] [35] However, what is important about the current study is that it has shown that reluctance to take part does not equate with satisfaction once the service is experienced. Therefore, it can be argued that focusing on patient recruitment processes, eg, whether reluctant patients are being recruited, is not a valid measure of patient satisfaction with the MUR service.
To our knowledge, this is the first quantitative, national study of patient satisfaction with the MUR service carried out in the UK. In addition, this is one of only a handful of "pharmacy adherence service" patient satisfaction questionnaires developed on the basis of patients' perspectives. This case is being made because, as demonstrated in the "Introduction" section, a highly relevant in-depth review by Panvelkar et al 13 unearthed only five relevant instruments, and our own search found one more research questionnaire, 16 none of which was developed through patient collaboration. And although the MUR-PSQ-v2 was not developed actively with patients, it was nonetheless based on patient perspectives and organized into a framework of MUR satisfaction as illustrated in a previously published paper. 19 Another strength of the current study is that the MUR-PSQ-v2 underwent thorough testing before, during, and after development to enhance its trustworthiness. With only 12 items included in the questionnaire, the instrument can be deemed to be easy to use and also to compute for the purpose of analysis. The study provides a mechanism for measuring people's satisfaction with the MUR service. This could be useful for auditing, comparing, and improving this pharmacy adherence service. In addition, since medication adherence reviews are offered as a pharmacy service across a number of European countries, 6 the MUR-PSQ-v2 provides a basis for adaptation and use in Europe and beyond.
A limitation of the study is the apparent low response rate for the survey, which was calculated by dividing the number of responses returned to the researchers by the total number of patient packs which pharmacists declared to have handed out, the latter determined during a retrospective telephone survey. The potential for an "over statement" bias cannot be ruled out, with pharmacists overstating the number of patient packs they distributed to patients in order to demonstrate better engagement with the project, which would superficially inflate the denominator and result in a lower response rate. On the face of it, the current response rate means that it is possible the survey did not capture responses from a large proportion of questionnaire recipients, either because they were unable to complete the questionnaire or were not satisfied with their MUR and did not want to report this.
Having said that, looking at recent literature in this field, the response rate is similar to another satisfaction study in pharmacy that also relied on the postal service 36 (19.2% response rate), which is important considering that studies which rely on handing out and being handed back questionnaires within the pharmacy setting still do not result in sizeable response rates (45.85% 37 and 58% 38 ). The decision to ask patients to post their questionnaires directly back to the researchers was made to reduce the chances of introducing unwanted bias. For example, posting the completed questionnaires directly to the research team meant that individual pharmacists delivering the service were bypassed, thereby eliminating the risk of pharmacists concealing less favorable returned responses from the research team, and the process was also thought to encourage honest patient responses by affording anonymity.
There is of course the possibility of selection bias in terms of whom the pharmacists chose to receive the MUR patient packs, which could only be addressed through more labor-intensive, less cost-effective methodologies relying on independent researchers handing out and collecting back the satisfaction questionnaires, which was outside of the scope of this study. However, by virtue of the questionnaire's design, it was important that patients completed the MUR-PSQ-v2 away from the pharmacy, having had the opportunity to reflect on their experience in order to answer the questions associated with factor 2, "judging the service".
Conclusion
This study has produced the MUR-PSQ-v2 as a tool to measure patient satisfaction with the adherence-focused MUR service. This is the first MUR-PSQ based on a framework built on patients' perspectives. Survey scores revealed that patients who completed and returned the survey were satisfied with their MUR service despite initial reluctance to participate. The development of the MUR-PSQ-v2 is a significant advancement for evaluating patient satisfaction with community pharmacy adherence services such as the MUR. Future research will confirm the findings of this study with a wider population of patients, and the questionnaire could be used for auditing, comparing, and improving the MUR and other adherence services in the UK and beyond.
Acknowledgments
The authors would like to acknowledge and thank the pharmacies, pharmacists, and patients who participated in the study. Without their contributions, the study could not have been successful. We also thank the East of England Respiratory Strategic Clinical Network for helping with the dissemination of questionnaires during the content validation phase and Day Lewis Pharmacy Group for helping to disseminate the questionnaires during the formal data collection period.
Disclosure
Dr Caroline Parkhurst is employed by the Day Lewis Pharmacy Group. The authors report no other conflicts of interest in this work.
1805
MUr patient satisfaction questionnaire Notes: The correlation between the variables was examined by creating a correlation matrix. Because the MUr-PsQ-v2 was constructed to measure one concept (patient satisfaction with an MUr), there is an expectation that the variables will correlate with each other. however, any variable with a consistently low correlation (less than 0.2) with other variables is potentially redundant. equally, a variable with a consistently high correlation (over 0.8) would cause multilinearity problems during factor analysis and might also need removing. Abbreviation: MUr-PsQ-v2, Medicines Use review patient satisfaction questionnaire, version 2. For example, 34% and 63% of 505 people responded "agree" or "strongly agree," respectively, in relation to item 12.
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